$TWST

Cho Dennis sold $30K of TWST

Cho Dennis (See Remarks) sold 346 shares of Twist Bioscience Corp (TWST) at $87.32 on 2026-06-22.

Original reporting
SEC EDGAR · Cho Dennis
Published Jun 24, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TWST
Neutral
medium confidence
Mentioned
$TWST
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TWSTNeutralLow
01

Why it matters

The disclosure updates the record of insider activity (346-share open-market sale) but does not introduce new operational or financial information about TWST.

02

Market read

Traders may monitor for insider-selling trends, but this single small sale is unlikely to drive a durable repricing without other catalysts.

03

What to watch

The article does not state motivations (taxes, diversification, planned liquidity) and provides no comparison to prior insider activity beyond the single transaction.

Relevance 3/10Novelty 3/10Timing: Form 4 filed 2026-06-24 (after-hours/late day disclosure) for a 2026-06-22 sale

Background

This is an SEC Form 4 insider transaction disclosure for Twist Bioscience (TWST).

Company-level read

Ticker impact

$TWSTNeutralMedium confidence
Context

Twist Bioscience officer Cho Dennis filed a Form 4 showing an open-market sale of 346 shares at $87.3224 on 2026-06-22.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless followed by additional insider selling or new fundamentals.

Evidence & confidence

The filing is a small, non-10b5-1 sale with disclosed price and post-transaction holdings, but it does not include new company performance, guidance, or regulatory/contract events.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None.

None.

Counterpoint

Insider sales are often liquidity-driven; without a pattern or accompanying 10b5-1/compensation context, the signal may be overstated.

Key entities

  • Twist Bioscience Corp

    Subject of the Form 4 insider transaction; officer Cho Dennis sold 346 shares at $87.3224.

  • Cho Dennis

    Officer who executed the open-market sale; holdings after transaction: 119,346 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TWSTHigh

Twist Bioscience TWST Stock Jumps On AI Drug Discovery Deals

Twist Bioscience (TWST) stock rose 10.19% after announcing AI drug discovery deals with Eli Lilly's TuneLab. The company reported $118.4M in quarterly revenue, a $35.1M net loss, and positive operating cash flow of $1.1M. Analysts have raised price targets, with Guggenheim setting it at $212. TWST is seen as a key player in AI-driven biotech.

$TWSTMed

Twist Bioscience Stock Jumps As Lilly AI Deal Fuels Bullish Target Hike

Twist Bioscience (TWST) stock rose 16.21% after announcing a partnership with Eli Lilly's AI drug discovery platform, TuneLab. The company reported Q3 revenue of $118.4M, with a gross margin of 52% but a net loss of $35.1M. Leerink raised its price target to $160, citing the AI-driven opportunity. TWST is trading at a high valuation with a price-to-sales ratio over 25.

$TWSTMed

Twist Bioscience Stock Jumps As AI Deals Fuel Bullish Target Hike

Twist Bioscience (TWST) stock rose 8.35% on September 24, 2026, driven by its AI partnership with Eli Lilly's TuneLab platform. The company's stock has seen significant gains recently, trading at $171.74 from $139 over a few weeks. TWST reported quarterly revenue of $118.38M, with a net loss of $35.05M. Leerink raised its price target to $160, citing AI drug discovery opportunities.